Insulin resistance relates to acetylcholine-induced microvascular vasoconstriction in a patient with vasospastic angina: Potential implication of causalities between hyperinsulinemia and coronary microcirculation failure

Heart and Vessels

Volumn 20, Issue 2, 2005, Pages 72-76

  Oyama, Naotsugu ^a   Urasawa, Kazushi ^a   Sakai, Hidetsugu ^a   Fujii, Satoshi ^a   Kitabatake, Akira ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Insulin resistance; Microvascular angina; Vasospasm

Indexed keywords

ACETYLCHOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; GLYCERYL TRINITRATE; INSULIN; ISOSORBIDE DINITRATE; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT;

AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY SPASM; ELECTROCARDIOGRAM; EPICARDIUM; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRACORONARY INFUSION; MALE; MICROCIRCULATION; MICROVASCULATURE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SMOKING; THORAX PAIN;

ACETYLCHOLINE; AGED; ANGINA PECTORIS; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY VASOSPASM; ELECTROCARDIOGRAPHY; HUMANS; HYPERINSULINISM; INFUSIONS, INTRA-ARTERIAL; INSULIN RESISTANCE; ISOSORBIDE DINITRATE; MALE; MICROCIRCULATION; NICORANDIL; TREATMENT OUTCOME; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 15844409196     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-004-0784-6     Document Type: Article

References (30)

1. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126
2. Harano Y, Suzuki M, Koyama Y, Kanda M, Yasuda S, Suzuki K, Takamizawa I (2002) Multifactorial insulin resistance and clinical impact in hypertension and cardiovascular diseases. J Diabetes Complications 16:19-23
3. Harano Y, Suzuki M, Shinozaki K, Hara Y, Ryomoto K, Kanazawa A, Nishioheda Y, Tsushima M (1996) Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach. Hypertens Res 19:S81-S85
4. Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, Harano Y (1995) Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina. Circulation 92:1749-1757
5. Swan JW, Walton C, Godsland IF, Crook D, Oliver MF, Stevenson JC (1994) Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men. Br Heart J 71:41-44
6. Nagai H, Takata S, Shimakura A, Sakagami S, Nakamura Y, Ohkuwa H, Kobayashi K (1998) Enhanced insulin response to oral glucose load in patients with angina pectoris associated with ST segment elevation in the absence of epicardial coronary arterial obstruction. Angiology 49:815-826
7. Nava P, Carbo R, Guarner V (2002) Coronary and femoral arterial contraction with high glucose, insulin, and glucose-insulin-potassium solution: Effects of hypoxia. Heart Vessels 16:57-63
8. Yamaguchi K, Higashiura K, Ura N, Murakami H, Hyakukoku M, Furuhashi M, Shimamoto K (2003) The effect of tumor necrosis factor-alpha on tissue specificity and selectivity to insulin signaling. Hypertens Res 26:389-396
9. Yasue H, Horio Y, Nakamura N, Fujii H, Imoto N, Sonoda R, Kugiyama K, Obata K, Morikami Y, Kimura T (1986) Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm. Circulation 74:955-963
10. Sekiya M, Okayama H, Suzuki M, Kobayashi T, Matsuoka H, Sumimoto T, Hamada M, Hiwada K (1993) Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: A possible vasospasm of small coronary arteries - a case report. Angiology 44:811-815
11. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L (1981) Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 30:219-225
12. King GL, Goodman AD, Buzney S, Moses A, Kahn CR (1985) Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75:1028-1036
13. Takeuchi M, Kanazawa A, Suzuki M, Hasegawa M, Kimura Y, Kodama K, Ryomoto K, Hattori Y, Harano Y (2000) Evaluation of factors during OGTT to correlate insulin resistance in non-diabetic subjects. Endocr J 47:535-542
14. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikami Y, Ogawa H (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81:482-490
15. Vita JA, Treasure CB, Nabel EG, McLenachan JM, Fish RD, Yeung AC, Vekshtein VI, Selwyn AP, Ganz P (1990) Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81:491-497
16. Kaplan NM (1989) The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520
17. Irving RJ, Walker BR, Noon JP, Watt GC, Webb DJ, Shore AC (2002) Microvascular correlates of blood pressure, plasma glucose, and insulin resistance in health. Cardiovasc Res 53:271-276
18. Reaven GM (2003) Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endocrinol Metab 88:2399-2403
19. Weiswasser JM, Nylen E, Arora S, Wakefield M, Sidawy AN (2002) Syndrome X and diabetes: What is the mystery? Semin Vasc Surg 15:216-224
20. Shinozaki K, Suzuki M, Ikebuchi M, Hirose J, Hara Y, Harano Y (1996) Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects. Metabolism 45:731-737
21. WHO study group (1985) Definition diagnosis and classification: Diabetes mellitus. Report of a WHO study group. World Health Organ Tech Rep Ser 727:9-25
22. Miwa K, Fujita M, Ejiri M, Sasayama S (1991) Usefulness of intracoronary injection of acetylcholine as a provocative test for coronary artery spasm in patients with vasospastic angina. Heart Vessels 6:96-101
23. Beltrame JF, Limaye SB, Wuttke RD, Horowitz JD (2003) Coronary hemodynamic and metabolic studies of the coronary slow flow phenomenon. Am Heart J 46:84-90
24. Kinoshita M, Hashimoto K, Ohbayashi Y, Inoue T, Taguchi H, Mitsunami K (1989) Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism. Am J Cardiol 63:71J-74J
25. Aizawa T, Ogasawara K, Nakamura F, Hirosaka A, Sakuma T, Nagashima K, Kato K (1989) Effect of nicorandil on coronary spasm. Am J Cardiol 63:75J-79J
26. Frydman AM, Chapelle P, Diekmann H, Bruno R, Thebault JJ, Bouthier J, Caplain H, Ungethuem W, Gaillard C, Le Liboux A, Renard A, Gaillot J (1989) Pharmacokinetics of nicorandil. Am J Cardiol 63:25J-33J
27. Chujo M, Mori H, Tanaka E, Nakazawa H, Okino H (1994) Inhibitory effects of nicorandil on sympathetic coronary vasoconstriction. Cardiovasc Res 28:917-922
28. Crystal GJ, Downey HF, Bashour FA (1981) Small vessel and total coronary blood volume during intracoronary adenosine. Am J Physiol 241:H194-H201
29. Kanatsuka H, Eastham CL, Marcus ML, Lamping KG (1992) Effects of nitroglycerin on the coronary microcirculation in normal and ischemic myocardium. J Cardiovasc Pharmacol 19:755-763
30. Hongo M, Takenaka H, Uchikawa S, Nakatsuka T, Watanabe N, Sekiguchi M (1995) Coronary microvascular response to intracoronary administration of nicorandil. Am J Cardiol 75:246-250